It has been reported from several Caucasian studies that there is an epidemiological association between hepatitis c virus infection and diabetes mellitus. The objective of this study was to determine whether any such relationship exists in a black African population. To determine the prevalence of Hepatitis C virus infection in Nigerians with diabetes mellitus in North-Eastern Nigeria. Hospital -based cross-sectional study. Medical out-patient clinic and the Blood bank of the Federal Medical Centre, Yola. Nigeria. From June, 2008 to December 2009, Two hundred and eighty consecutively recruited diabetes mellitus patients comprising 108 males and 172 females were screened for HCV infection. These were compared with five hundred and ninetyfive voluntary blood donors who were screened during the same period. Serological testing for HCV infection was carried out with anti-HCV using Enzyme Linked Immuno-sorbent Assay (ELISA) method. The bio-data of the patients, history and duration of diabetes mellitus, history of jaundice, blood transfusion were recorded on a proforma. Out of the 280 diabetes mellitus patients tested, twenty-six were positive for anti-HCV antibodies giving an infection rate of 9.3% compared with fourteen subjects out of 595 voluntary blood donors 2.4% (p=0.0000105). History of blood transfusion, and jaundice was positively correlated with presence of HCV infection in diabetic patients. Hepatitis C virus is more common in Nigerian patients with diabetes mellitus than in non-diabetic control subjects. It may be necessary to screen patients with diabetes mellitus for hepatitis c virus infection particularly those with history of blood transfusion and jaundice.
INTRODUCTION
Diabetes mellitus (DM) is a metabolic syndrome of multiple aetiologies characterised by chronic hyperglycaemia with disturbances of carbohydrates, fat and protein metabolism resulting from defects in insulin secretion, insulin action or both (Olokoba et al, 2007) . DM may result from the destruction of the beta cells of the pancreas with consequent insulin deficiency or resistance to insulin action at the receptor site (Olokoba et al, 2007) . DM can be broadly classified into type 1DM, type 2 DM, gestational DM, and other specific types of DM (Olokoba et al, 2007) .
Type 2 DM accounts for over 90% of all cases of DM (Alberti et al, 1990) . Over 100 million people are diabetic worldwide and probably as many are not diagnosed (Alberti et al, 1990) . A national survey in Nigeria showed a prevalence rate of 2.7% among Nigerians (Akinkugbe, 1997) .
At present, there are an estimated 170 million Hepatitis C virus (HCV) carriers worldwide, most of who are thought to be in the developing countries (Maddava et al, 2002) . HCV plays an important role in the causation of chronic liver disease (CLD) (Lesi et al, 2002) , and has become the leading cause of liver cirrhosis and primary liver cell carcinoma (PLCC) in North America, Southern Europe and Japan (Colquhon, 1996; Cheng, 1995) .
Infection with HCV affects not only the liver but also other extra-hepatic tissues as well (Ali et al, 2007) . A number of extra-hepatic manifestations have been recognised including DM (Sene et al, 2004; Mason, 2001) . Although it remains to be determined whether HCV leads to DM or vice versa, but it is argued that patients with DM have an increased risk of exposure to HCV owing to the nature of the disease and its inherent complications or frequent parenteral exposure (Ali et al, 2007) .
It has been reported from several Caucasian studies that there is an epidemiological association between HCV infection and DM. The objective of this study was to determine whether any such relationship exists in a black African population. We therefore determined the prevalence of HCV infection in Nigerians with DM in North-Eastern Nigeria.
MATERIALS AND METHODS
The serum samples of all consecutively recruited patients with confirmed DM were screened for HCV using rapid test ELISA kits (ACON Laboratories, Inc San Diego CA 92121 USA) to detect antibodies to hepatitis C virus (anti-HCV). Similarly, the serum samples of all consecutively recruited voluntary blood donors (VBD) were screened for HCV infection. All positive serum samples were re-tested to eliminate false positives.
Their bio data was obtained. Written informed consent was obtained from each patient. The study was approved by the Ethics and Research committee of the Federal Medical Centre, Yola, Nigeria.
Analysis:
The data obtained were analysed using the statistical package for social sciences (SPSS, version 11.0) statistical software.
RESULTS
At the conclusion of the study, out of the 280 DM patients tested, twenty-six were positive for anti-HCV antibodies giving an infection rate of 9.3% compared with fourteen subjects out of 595 VBD.
History of blood transfusion and jaundice is positively correlated with presence of HCV infection in diabetic patients.
Age
The age of the DM patients studied ranged from 26-85years with a mean of 51.5+/-12.0years. There was a steady increase in the age of the DM patients until a plateau at 5 th decade (i.e. 40-49years). Thereafter there was a decline. Majority of the DM patients were in the 40-59 year age bracket (57.5%). The age range of the VBD was from 18-61 years with a mean of 31.3+/-7.9 years. Majority of the VBD were in the 20-39 year age bracket (83.3%). See table 1.
Gender: Out of the 280 DM patients screened, 108 patients (38.6%) were males while 172 patients (61.4%) were females, giving a male to female ratio of 1:1.59. while out of the 595 VBD screened, 571 were males (96.0%) while 24 were females (4.0%) giving a male to female ratio 23.8:1. There is no gender predilection in the occurrence of HCV infection in DM patients. See table 2. 
DISCUSSION
A review of the literature shows that controversy exists in the relationship between HCV infection and DM (Nwokediuko and Oli, 2008; Adegoke et al, 2008; Balogun et al, 2006) . Our study shows a significant increase in HCV infection in patients with DM compared with non-diabetic controls as 9.3% of our diabetic patients were found to have HCV infection compared with 2.4% of non-diabetic VBD. A review of the local literature shows that there are few Nigerian studies with which to compare. Nwokediuko and Oli (2008) in Enugu, South-eastern, Nigeria found that HCV infection is more common in DM patients compared with their non-diabetic controls (14.1% versus 3.7%). However, Adegoke et al (2008) in Ileife, South-west, Nigeria found a low prevalence of HCV infection (0.01%) among DM patients. Similarly, Balogun et al (2006) found a low prevalence of HCV infection in their DM patients in Ibadan, South-west, Nigeria. Ali et al (2007) in their study amongst Pakistanis found that HCV infection occurred more in DM patients. Similarly, Bahtiyar et al (2004) found a higher prevalence of HCV seropositivity in DM patients than in the general population in the United States of America. Furthermore, Knobler and Schattner (2001) found a positive association between HCV infection and DM among their Israeli patients. Manson et al (1999) and Ryu et al (2001) working separately, found a positive association between HCV infection and DM among American and Korean patients respectively. Conversely, Mangia et al (1998) found a negative association between HCV infection and DM among their Italian patients. Various reasons have been adduced for the increased occurrence of HCV infection in DM patients. These are frequent parenteral injections and exposure due to frequent insulin administration, extra-hepatic manifestations of HCV infection which includes DM, and the fact that patients with liver diseases are known to have a higher prevalence of glucose intolerance. A higher prevalence of DM in HCV related liver cirrhosis in comparison with cirrhosis secondary to other causes has also been postulated (Chen et al, 2003) . There is scant evidence for infection of pancreas by HCV and destruction of beta cells either directly by HCV or by an immune response, although HCV ribonucleic acid has been found in pancreatic tissue (Everhart, 1999) . In this study, only anti-HCV antibodies were used to screen for HCV infection. HCV RNA was not assayed for. If HCV RNA was assayed for, the actual HCV infection rate would probably be higher than the present reported figure of 9.3%. We also observed that a history of blood transfusion and a past history of jaundice are positive predictors of HCV infection in patients with DM. From this study, we did not find any relationship between gender and the presence of HCV seropsitivity in DM patients. This is similar to the findings of Ali et al (2007) who did not find any relationship between gender and the risk of HCV infection. In contrast to this, Cacoub et al (1999) found female gender as a frequent factor in the extrahepatic manifestation of HCV infection In conclusion, HCV infection is more common in Nigerians with DM. A past history of blood transfusion and a past history of jaundice are independent predictors of HCV infection in DM patients. There is no relationship between gender and the occurrence of seropositivity to HCV infection in DM patients.
